Andy Studna


Data Aggregation and AI in Use Today

January 11, 2022

Martin Gouldstone, Chief Business Officer of Life Sciences, Sensyne, updates us on the status of AI in data used for clinical research, the difference between ethical AI vs. AI, and what Sensyne is trying to achieve in this space.

SCOPE Preview: ClinOps Education and Networking

December 20, 2021

Micah Lieberman, Executive Director, Conferences for CHI and Co-Founder, VP, Community and Business Development of ClinEco talks about what to expect at the upcoming SCOPE conference in February, tips on how to get the most out of your experience, life during the pandemic, and much more.

Patient Advocacy in All Areas of Drug Development

November 16, 2021

Dr. Lise Lund Kjems, Chief Medical Officer at Cyclo Therapeutics, talks about Cyclo’s investigational therapy for Niemann-Pick Disease Type C and gives insight into rare disease drug development, with an emphasis on ensuring trial design includes holistic and specific patient concerns.

The Life of a Quality Professional

November 02, 2021

Bob Chaplinsky, Director Corporate Quality Compliance at UCB, discusses the trajectory of quality management systems in pharma, the importance of change management when implementing new systems, and staying on top of compliance and regulatory changes on a global scale.

Keeping Sites at the Center of Clinical Research

October 19, 2021

Mary Costello, Head of Site and Investigator Network at Medable, and Pat Larrabee, CEO of Rochester Clinical Research, discuss their extensive careers in the clinical trials industry, as well as talk about their article in our October issue, “Why Siteless Trials Won’t Work.”